Transmission of drug-resistant strains of HIV-1: unfortunate, but inevitable

被引：16

作者：

Cohen, OJ ^{[1
]}

Fauci, AS ^{[1
]}

机构：

[1] NIAID, NIH, Bethesda, MD 20892 USA

来源：

LANCET | 1999年 / 354卷 / 9180期

关键词：

D O I：

10.1016/S0140-6736(99)90106-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：697 / 698

页数：2

共 15 条

[1]

BARTLETT JG, 1998, 12 INT C AIDS GEN SW

[2]

BAXTER JD, 1999, 6 C RETR OPP INF CHI

[3] Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].

Carpenter, CCJ ;

Fischl, MA ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schooley, RT ;

Thompson, MA ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86

[4] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].

Chun, TW ;

Stuyver, L ;

Mizell, SB ;

Ehler, LA ;

Mican, JAM ;

Baseler, M ;

Lloyd, AL ;

Nowak, MA ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197

[5]

*DEP HLTH HUM SERV, 1998, ANN INTERN MED, V128, P1079

[6] Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial [J].

Durant, J ;

Clevenbergh, P ;

Halfon, P ;

Delgiudice, P ;

Porsin, S ;

Simonet, P ;

Montagne, N ;

Boucher, CAB ;

Schapiro, JM ;

Dellamonica, P .

LANCET, 1999, 353 (9171) :2195-2199

[7] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].

Finzi, D ;

Blankson, J ;

Siliciano, JD ;

Margolick, JB ;

Chadwick, K ;

Pierson, T ;

Smith, K ;

Lisziewicz, J ;

Lori, F ;

Flexner, C ;

Quinn, TC ;

Chaisson, RE ;

Rosenberg, E ;

Walker, B ;

Gange, S ;

Gallant, J ;

Siliciano, RF .

NATURE MEDICINE, 1999, 5 (05) :512-517

[8] Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy [J].

Furtado, MR ;

Callaway, DS ;

Phair, JP ;

Kunstman, KJ ;

Stanton, JL ;

Macken, CA ;

Perelson, AS ;

Wolinsky, SM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1614-1622

[9] Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors [J].

Hecht, FM ;

Grant, RM ;

Petropoulos, CJ ;

Dillon, B ;

Chesney, MA ;

Tian, H ;

Hellmann, NS ;

Bandrapalli, NI ;

Digilio, L ;

Branson, B ;

Kahn, JO .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05) :307-311

[10] Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management [J].

Hirsch, MS ;

Conway, B ;

D'Aquila, RT ;

Johnson, VA ;

Brun-Vézinet, F ;

Clotet, B ;

Demeter, LM ;

Hammer, SM ;

Jacobsen, DM ;

Kuritzkes, DR ;

Loveday, C ;

Mellors, JW ;

Vella, S ;

Richman, DD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1984-1991

← 1 2 →